CPG brands that ride this wave will be supported by GLP-1 brand ad spending thats predicted to soar from $1B in 2023 to an astounding $100B by 2030
Anastasia Efimenko, Lomonosov Moscow State University, Russia Updates Copyright 2021 Skuratovskaia, Vulf, Chasovskikh, Komar, Kirienkova, Shunkin, Zatolokin and Litvinova
For those interested in trying it, Pendulum Metabolic Daily is currently available with up to 36% savings through a subscription plan, and purchases may be eligible for HSA/FSA reimbursement
19 In the study, the researchers used a large electronic health record database to conduct a nationwide retrospective cohort study to assess the association of semaglutide with the incidence and recurrence of suicidal ideation compared with non-GLP1R agonist anti-obesity medications in individuals with overweight or obesity